Summary

CB Therapeutics

Founded in 2015

Description

CB Therapeutics is an innovative producer of high value molecules, compounds and rare ingredients from simple feedstock utilizing many different types of hosts and systems, including yeast, bacteria and cell free expression systems. CB Therapeutics ex...

Strengths

  • CB Therapeutics has a strong market share in their industry
  • Revenue generated per employee is greater than industry average
  • Since CB Therapeutics was founded, the company has grown faster than the industry average

Annual Revenue

CB Therapeutics's annual revenue

$4677000

Based on Kona Equity data

  • Revenue per employee

    $259833

  • Annual revenue growth since founding

    $519666

Employee Count

18 employees

Executives

Kirsten Tang

Research Bio Associate

k**@cbthera.com

Diana Castillo

Manager, Laboratory

d**@cbthera.com

Erin Scott

Associate Director, Microbiology

e**@cbthera.com

James Wade

Director, Analytical Chemistry

j**@cbthera.com

Tyler Huelsman

Senior Research Associate

t**@cbthera.com

Laura Peiffer

Associate Director, Research & Development

l**@cbthera.com

Thanos Karavokiris

Vice President, Operations

t**@cbthera.com

Phone Therapeutics

Founder & Chief Executive Officer

p**@cbthera.com

Lilibeth Loumakis

Laboratory Technician

l**@cbthera.com

Sher Butt

Founder & Chief Executive Officer

s**@cbthera.com

Beatriz Sanchez

Fermentation Associate

b**@cbthera.com

Brittany Ferrell

Bio Senior Research Associate

b**@cbthera.com

G Score - 3

The G Score is an eight-point scale where firms are given a score of 1 for each of the criteria that they pass. The G score compares a company against the industry median to find those that are healthy and growing.

  • G1 Revenue is greater than the industry median.
  • G2 Income per employee more than industry average.
  • G6 Annual revenue growth since founding is higher than the industry average.

Location

2717 Loker Ave W Ste A 
Carlsbad, CA  None

Unlock unlimited leads

Get access to millions of contacts, companies, emails, and more!

Similar Companies

Vala Sciences Inc

valasciences.com
  • Founded in 2004
  • Location: San Diego, CA
  • Annual Revenue: $3.9M
  • Employees: 17
  • Vala Sciences helps drug developers and researchers understand how human cells respond to their drug compounds. By precisely measuring up to three channels of single-cell iPSC kinetic data in real time and comparing cell response with known human bench...

Hyasynth Bio

hyasynthbio.com
  • Founded in 2014
  • Location: Montreal, Quebec
  • Annual Revenue: $5.5M
  • Employees: 26
  • Natural molecules or derivatives make up more than half of the current drugs on the market with applications to nearly every disease known to humans. Salicylic acid, morphine, cannabinoids and insulin are a few examples. Our specialty is in producing t...

Renew Biopharma Inc

renewbiopharma.com
  • Founded in 2016
  • Location: San Diego, CA
  • Annual Revenue: $1.5M
  • Employees: 6
  • Renew Biopharma is a drug discovery company that specializes in synthetic biology for neurotherapeutics. They have developed a proprietary synthetic biology platform that allows them to produce a pipeline of drug molecules for neuroinflammatory conditi...

Key Information

  • SIC: 28; 283
  • NAICS: 32; 325
Disclaimer: These numbers are estimates and any other company information is based off our proprietary algorithms and by no means should be accepted as 100% factual. Kona Equity is in no way affiliated with CB Therapeutics.

See similar companies

Frequently Asked Questions


What is CB Therapeutics's official website?

CB Therapeutics's official website is cbthera.com


What is CB Therapeutics's revenue?

CB Therapeutics's annual revenue is $4.7 M.


What is CB Therapeutics's SIC code?

CB Therapeutics's SIC: 28; 283


What is CB Therapeutics's NAICS code?

CB Therapeutics's NAICS: 32; 325.


How many employees does CB Therapeutics's have?

CB Therapeutics has 18 employees


What industry does CB Therapeutics belong to?

CB Therapeutics is in the industry of Pharmaceuticals.

Next step

Visitors review